Solifenacin Succinate
- Product NDC
- 0093-5263
- 11-digit product format
- 000935263
- Labeler code
- 0093
- Product ID
- 0093-5263_c5950184-53c8-42f9-bc57-4ad02dda28ed
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Solifenacin Succinate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA091464
- Marketing category
- ANDA
- Marketing start
- 2019-04-22
- Marketing end
- 2021-08-30
- Substance
- SOLIFENACIN SUCCINATE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-5263-56 | 00093526356 | 30 TABLET, FILM COATED in 1 BOTTLE (0093-5263-56) | 2019-04-22 | 2021-08-30 | No | No | Current |
| 0093-5263-98 | 00093526398 | 90 TABLET, FILM COATED in 1 BOTTLE (0093-5263-98) | 2019-04-22 | 2021-06-30 | No | No | Current |